• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsHyundai Pharmaceutical
    Picture of Hyundai Pharmaceutical logo

    004310 — Hyundai Pharmaceutical Share News

    KR₩6,8300.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    • Market Cap
      KR₩211bn
    • Enterprise Value
      KR₩238bn
    • Revenue
      KR₩192bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 004310 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    004310 Dividends
    • S.Korea morning-after pill makers jump as court strikes down abortion law

      12/04/2019 02:21
    • S.Korean stocks close little changed; won edges lower

      11/04/2019 07:56
    • Brief: Acerus Pharmaceuticals Announces Approval Of Natesto In South Korea

      14/06/2018 12:05
    • Brief: Mithra Pharmaceuticals To Commercialise Estelle In South Korea With Hyundai Pharm

      05/06/2018 06:39
    • Brief: Hyundai Pharmaceutical to pay annual cash dividend as 50 won/share

      04/01/2018 07:33
    • Brief: Hyundai Pharmaceutical to raise 13 bln won via rights issue

      25/09/2017 10:59
    • Brief: Hyundai Pharmaceutical to pay annual dividend as 47.5 won/share for FY 2016

      10/01/2017 09:49
    • Brief: Acerus announces NATESTO license agreement with Hyundai Pharm

      15/12/2016 22:30

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.